NLRP3 and cystic fibrosis: Limiting the abnormal mitochondrial Ca2+-uptake in CF and mediating pharmacological inhibition of MCU, with KB-R7943, attenuated the pathogen-dependent ROS production and mitochondrial dysfunction, preventing the activation of NLRP3 inflammasome and UPRmt in vitro and in vivo [142].